Records containing: MAFLD
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-09PRObiotic Mixed With Exercise THErapy USe in MAFLD (PROMETHEUS in MAFLD)
-
CLINICAL_TRIALS study record update · 2026-03-24The Effect of Alogliptin Combined With Pioglitazone and Metformin Hydrochloride Tablets on Glucose and Lipid Metabolism and Islet Function in Patients With Type 2 Diabetes Mellitus Complicated With Metabolic Dysfunction-associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-17Construction of Prediction Models for Metabolic - Associated Fatty Liver Disease and Liver Fibrosis in HIV - Infected Individuals
-
CLINICAL_TRIALS study record update · 2026-03-13Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh
-
CLINICAL_TRIALS study record update · 2026-02-05Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide - a Randomized Controlled Trial.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-26Assessing the Utility of AI Models in MAFLD Diagnosis: Comparison With Traditional Non-Invasive Fibrosis Scores.
-
CLINICAL_TRIALS study record update · 2025-12-22Real-World Clinical Practice Study on the Effectiveness of Semaglutide Over 154 Weeks in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-12-22Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model
-
CLINICAL_TRIALS study record update · 2025-11-21Evaluation of Agreement Between the Handheld Elastography Device and iLivTouch for Multi-Position Liver Assessment in Chronic Liver Disease
-
CLINICAL_TRIALS study record update · 2025-11-18A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD
-
CLINICAL_TRIALS study record update · 2025-10-02Imaging-Based Biomarkers for Non-Invasive Pediatric Liver Diagnostics
-
CLINICAL_TRIALS study record update · 2025-09-30A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults
-
CLINICAL_TRIALS study record update · 2025-05-11Re Evaluation of the Clinical Efficacy of Ganzhixiao Capsules Based on MRI-PDFF in the Treatment of Metabolic Related Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-04-11The Role of Estimated Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver Disease and Its Severity in Patients With Metabolic Syndrome.